.

Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer. - Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer.

Argenta PA, Um I, Kay C, Harrison D, Faratian D, Sueblinvong T, Geller MA, Langdon SP. Gynecol Oncol. 2013 Nov;131(2):368-73.

A large network of interconnected signaling pathways in human ovarian follicles - A large network of interconnected signaling pathways in human ovarian follicles

Yoo SW, Savchev S, Sergott L, Rezai T, Lopez MF, Von Wald T, Eaton JL, Reindollar R, Usheva A. Reprod Sci. 2011 May;18(5):476-84.

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated - Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated

Taylor KJ, Sims AH, Liang L, Faratian D, Muir M, Walker G, Kuske B, Dixon JM, Cameron DA, Harrison DJ, Langdon SP. Breast Cancer Res. 2010;12(3):R39.

The expression of osteoclastogenesis-associated factors and osteoblast response - The expression of osteoclastogenesis-associated factors and osteoblast response

Morrissey C, Lai JS, Brown LG, Wang YC, Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E, Nelson PS, Vessella RL. Prostate. 2010 Mar 1;70(4):412-24.

Pathway-based biomarker search by high-throughput proteomics profiling of - Pathway-based biomarker search by high-throughput proteomics profiling of

Lawlor K, Nazarian A, Lacomis L, Tempst P, Villanueva J. J Proteome Res. 2009 Mar;8(3):1489-503.

Antiestrogen therapy is active in selected ovarian cancer cases: the use of - Antiestrogen therapy is active in selected ovarian cancer cases: the use of

Smyth JF, Gourley C, Walker G, MacKean MJ, Stevenson A, Williams AR, Nafussi AA, Rye T, Rye R, Stewart M, McCurdy J, Mano M, Reed N, McMahon T, Vasey P, Gabra H, Langdon SP. Clin Cancer Res. 2007 Jun 15;13(12):3617-22.